HRMY
Harmony Biosciences Holdings Inc

17,083
Mkt Cap
$2.26B
Volume
949.00
52W High
$40.93
52W Low
$25.52
PE Ratio
12.47
HRMY Fundamentals
Price
$39.59
Prev Close
$39.27
Open
$39.46
50D MA
$31.56
Beta
0.86
Avg. Volume
946,186.74
EPS (Annual)
$2.51
P/B
2.73
Rev/Employee
$2.67M
Loading...
Loading...
News
all
press releases
Federated Hermes Inc. Reduces Stock Position in Harmony Biosciences Holdings, Inc. $HRMY
Federated Hermes Inc. cut its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 33.2% during the second quarter, according to the company in its most recent 13F filing...
MarketBeat·2h ago
News Placeholder
More News
News Placeholder
Harmony Biosciences Presents Clinically Meaningful Open-Label Extension Study Effectiveness Data for EPX-100 in Dravet Syndrome
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced the presentation of initial open-label extension (OLE) data from the companys ongoing Phase 3 ARGUS trial investigating EPX-100...
Business Wire·4d ago
News Placeholder
Marshall Wace LLP Increases Stock Holdings in Harmony Biosciences Holdings, Inc. $HRMY
Marshall Wace LLP boosted its stake in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 36.3% in the second quarter, according to its most recent disclosure with the SEC...
MarketBeat·4d ago
News Placeholder
Capital Fund Management S.A. Invests $1.14 Million in Harmony Biosciences Holdings, Inc. $HRMY
Capital Fund Management S.A. bought a new stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) during the second quarter, according to the company in its most recent disclosure...
MarketBeat·7d ago
News Placeholder
Harmony Biosciences to Present New Open-Label Extension Data from Phase 3 ARGUS Trial at the 2025 American Epilepsy Society Annual Meeting
Harmony Biosciences Holdings, Inc. (Nasdaq: HRMY), today announced that it will highlight new open-label extension data from the companys investigation of EPX-100 (clemizole hydrochloride) in the...
Business Wire·10d ago
News Placeholder
Prudential Financial Inc. Has $4.79 Million Stake in Harmony Biosciences Holdings, Inc. $HRMY
Prudential Financial Inc. boosted its stake in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 46.1% in the second quarter, according to its most recent Form 13F filing with the...
MarketBeat·10d ago
News Placeholder
Boston Partners Takes $19.40 Million Position in Harmony Biosciences Holdings, Inc. $HRMY
Boston Partners purchased a new position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) in the 2nd quarter, according to the company in its most recent filing with the...
MarketBeat·12d ago
News Placeholder
Harmony Biosciences Holdings, Inc. $HRMY Shares Bought by American Century Companies Inc.
American Century Companies Inc. grew its holdings in Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 16.5% in the second quarter, according to its most recent disclosure with the...
MarketBeat·12d ago
News Placeholder
Geode Capital Management LLC Raises Position in Harmony Biosciences Holdings, Inc. $HRMY
Geode Capital Management LLC increased its position in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 9.2% in the 2nd quarter, according to its most recent disclosure...
MarketBeat·13d ago
News Placeholder
Summit Global Investments Sells 8,441 Shares of Harmony Biosciences Holdings, Inc. $HRMY
Summit Global Investments lessened its holdings in shares of Harmony Biosciences Holdings, Inc. (NASDAQ:HRMY - Free Report) by 28.9% during the second quarter, according to the company in its most...
MarketBeat·15d ago

Latest HRMY News

View

Advertisement|Remove ads.

Advertisement|Remove ads.